Adarza BioSystems garners $25 mn Series D

St. Louis, Missouri-based Adarza BioSystems, a biotech firm, has secured $25 million in Series D funding.

4 February 2020•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles